The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Prostate Cancer Market Research Report 2025
Synopsis
Prostate cancer is cancer that occurs in the prostate.
The global Prostate Cancer market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Prostate Cancer is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Prostate Cancer is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Prostate Cancer in Age Below 55 is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Prostate Cancer include Astellas, Inc., AstraZeneca plc, Johnson & Johnson, Sanofi S.A, Bristol Myers Squibb (BMS) and Bayer AG, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Prostate Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Cancer.
Report Scope
The Prostate Cancer market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Prostate Cancer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prostate Cancer companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Astellas, Inc.
AstraZeneca plc
Johnson & Johnson
Sanofi S.A
Bristol Myers Squibb (BMS)
Bayer AG
Segment by Type
Chemotherapy
Hormonal Therapy
Targeted Therapy
Immunotherapy
Segment by Application
Age Below 55
Age 55-75
Age Above 75
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prostate Cancer companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Prostate cancer is cancer that occurs in the prostate.
The global Prostate Cancer market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Prostate Cancer is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Prostate Cancer is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Prostate Cancer in Age Below 55 is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Prostate Cancer include Astellas, Inc., AstraZeneca plc, Johnson & Johnson, Sanofi S.A, Bristol Myers Squibb (BMS) and Bayer AG, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Prostate Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Cancer.
Report Scope
The Prostate Cancer market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Prostate Cancer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prostate Cancer companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Astellas, Inc.
AstraZeneca plc
Johnson & Johnson
Sanofi S.A
Bristol Myers Squibb (BMS)
Bayer AG
Segment by Type
Chemotherapy
Hormonal Therapy
Targeted Therapy
Immunotherapy
Segment by Application
Age Below 55
Age 55-75
Age Above 75
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prostate Cancer companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate Cancer Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Chemotherapy
1.2.3 Hormonal Therapy
1.2.4 Targeted Therapy
1.2.5 Immunotherapy
1.3 Market by Application
1.3.1 Global Prostate Cancer Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Age Below 55
1.3.3 Age 55-75
1.3.4 Age Above 75
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Prostate Cancer Market Perspective (2019-2030)
2.2 Prostate Cancer Growth Trends by Region
2.2.1 Global Prostate Cancer Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Prostate Cancer Historic Market Size by Region (2019-2024)
2.2.3 Prostate Cancer Forecasted Market Size by Region (2025-2030)
2.3 Prostate Cancer Market Dynamics
2.3.1 Prostate Cancer Industry Trends
2.3.2 Prostate Cancer Market Drivers
2.3.3 Prostate Cancer Market Challenges
2.3.4 Prostate Cancer Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prostate Cancer Players by Revenue
3.1.1 Global Top Prostate Cancer Players by Revenue (2019-2024)
3.1.2 Global Prostate Cancer Revenue Market Share by Players (2019-2024)
3.2 Global Prostate Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Prostate Cancer Revenue
3.4 Global Prostate Cancer Market Concentration Ratio
3.4.1 Global Prostate Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Revenue in 2023
3.5 Prostate Cancer Key Players Head office and Area Served
3.6 Key Players Prostate Cancer Product Solution and Service
3.7 Date of Enter into Prostate Cancer Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Prostate Cancer Breakdown Data by Type
4.1 Global Prostate Cancer Historic Market Size by Type (2019-2024)
4.2 Global Prostate Cancer Forecasted Market Size by Type (2025-2030)
5 Prostate Cancer Breakdown Data by Application
5.1 Global Prostate Cancer Historic Market Size by Application (2019-2024)
5.2 Global Prostate Cancer Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Prostate Cancer Market Size (2019-2030)
6.2 North America Prostate Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Prostate Cancer Market Size by Country (2019-2024)
6.4 North America Prostate Cancer Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Prostate Cancer Market Size (2019-2030)
7.2 Europe Prostate Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Prostate Cancer Market Size by Country (2019-2024)
7.4 Europe Prostate Cancer Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Prostate Cancer Market Size (2019-2030)
8.2 Asia-Pacific Prostate Cancer Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Prostate Cancer Market Size by Region (2019-2024)
8.4 Asia-Pacific Prostate Cancer Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Prostate Cancer Market Size (2019-2030)
9.2 Latin America Prostate Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Prostate Cancer Market Size by Country (2019-2024)
9.4 Latin America Prostate Cancer Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prostate Cancer Market Size (2019-2030)
10.2 Middle East & Africa Prostate Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Prostate Cancer Market Size by Country (2019-2024)
10.4 Middle East & Africa Prostate Cancer Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Astellas, Inc.
11.1.1 Astellas, Inc. Company Detail
11.1.2 Astellas, Inc. Business Overview
11.1.3 Astellas, Inc. Prostate Cancer Introduction
11.1.4 Astellas, Inc. Revenue in Prostate Cancer Business (2019-2024)
11.1.5 Astellas, Inc. Recent Development
11.2 AstraZeneca plc
11.2.1 AstraZeneca plc Company Detail
11.2.2 AstraZeneca plc Business Overview
11.2.3 AstraZeneca plc Prostate Cancer Introduction
11.2.4 AstraZeneca plc Revenue in Prostate Cancer Business (2019-2024)
11.2.5 AstraZeneca plc Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Detail
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Prostate Cancer Introduction
11.3.4 Johnson & Johnson Revenue in Prostate Cancer Business (2019-2024)
11.3.5 Johnson & Johnson Recent Development
11.4 Sanofi S.A
11.4.1 Sanofi S.A Company Detail
11.4.2 Sanofi S.A Business Overview
11.4.3 Sanofi S.A Prostate Cancer Introduction
11.4.4 Sanofi S.A Revenue in Prostate Cancer Business (2019-2024)
11.4.5 Sanofi S.A Recent Development
11.5 Bristol Myers Squibb (BMS)
11.5.1 Bristol Myers Squibb (BMS) Company Detail
11.5.2 Bristol Myers Squibb (BMS) Business Overview
11.5.3 Bristol Myers Squibb (BMS) Prostate Cancer Introduction
11.5.4 Bristol Myers Squibb (BMS) Revenue in Prostate Cancer Business (2019-2024)
11.5.5 Bristol Myers Squibb (BMS) Recent Development
11.6 Bayer AG
11.6.1 Bayer AG Company Detail
11.6.2 Bayer AG Business Overview
11.6.3 Bayer AG Prostate Cancer Introduction
11.6.4 Bayer AG Revenue in Prostate Cancer Business (2019-2024)
11.6.5 Bayer AG Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
